20 December 2012 | News | By BioSpectrum Bureau
Singapore: ASKLEP, a leading Tokyo-based provider of clinical research services, has joined the Medidata Solutions Partner Program as part of its strategy to expand its existing offerings and further invest in its ability to support the entire clinical trial lifecycle.
With the goal of streamlining key areas of the clinical trials process for its sponsor customers, ASKLEP will pursue several accreditations across Medidata's cloud-based platform that will significantly bolster its organization's ability to effectively support sponsors. ASKLEP plans to seek accreditation in order to provide services around Medidata's solutions for electronic data capture (EDC) and clinical data management (CDM), safety data capture, monitoring, randomization and trial supply management, and medical coding.
With subsidiaries in China, Taiwan and Korea, ASKLEP provides a range of services to sponsors in the Asia Pacific region, including clinical research services in monitoring, data management, biostatistics and clinical research associate (CRA) training. The company will offer the Medidata Platform to increase both efficiency and quality of its clinical trials and post-marketing studies given the large network of sites across Japan.
"It's critical that our partners share our mission and dedication to improving the clinical trial process for research sponsors," said Mr Masahito Ikeda, corporate officer, deputy division director, clinical information, at ASKLEP. "We've been impressed with Medidata's track record streamlining global trials of all sizes and phases and the strong preference among sites to use the Medidata platform for electronic patient data capture."
Medidata's expertise and experience working in the Asia-Pacific region was also a key factor in ASKLEP's decision to join its partner program and pursue several accreditations to support its strategy. Medidata currently has thirteen partners headquartered in this region.